Starting on:
Jan 28, 2026
Ending on:
Jan 28, 2026
Moderator(s):
Max Credits:
3 Points
Provider:
Daktari Online
Claim Points
Jan 28, 2026
Ending on:
Jan 28, 2026
Moderator(s):
Dr.
Shalini Kumar
Group Product Manager – Anglo-Africa Business
Venue: Group Product Manager – Anglo-Africa Business
Max Credits:
3 Points
Provider:
Daktari Online
Claim Points
Managing Type 2 Diabetes with Comorbidities: Clinical Insights with Empagliflozin
Starting on:
Jan 28, 2026
Jan 28, 2026
Ending on:
Jan 28, 2026
Jan 28, 2026
Venue:
Description
Theme: Looking Beyond Glycemia with Empagliflozin.
Objectives
LEARNING OBJECTIVES:
1. Explain the role of empagliflozin in slowing the progression of chronic kidney disease and improving renal
outcomes in high-risk patients, based on real-world nephrology case insights.
2. Evaluate the impact of empagliflozin on heart failure outcomes across the cardio-renal continuum, using
evidence-based and real-world cardiology case discussions.
3. Apply practical patient-selection, initiation, and monitoring strategies for empagliflozin in patients with
heart failure and/or chronic kidney disease to optimize clinical outcomes and safety.
Presenters
-
Dr.
Joseph Gyagenda
Nephrologist
-
Dr.
Hery Mwandolela
Cardiologist